Increasing gamma-aminobutyric acid (GABA) and balancing glutamate, brain chemicals called neurotransmitters, may help alleviate symptoms of fibromyalgia (FMS) and chronic fatigue syndrome (ME/CFS).

The following sections will present novel GABAergic interventions currently being investigated. Table 5. GABA modulators in clinical trials for AUD and alcohol withdrawal treatment (Source: ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Scientists, researchers and private health organizations scrambled to preserve as much federal public health data and ...

In the meantime, a general communications gag order bans any CDC scientist from submitting any new scientific findings to the ...

Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...

Sherry Gaba, LCSW, is a licensed psychotherapist ... Sherry has worked at some of the top rehabilitation centers, including Promises Treatment Center and Soba Recovery Center in Malibu.

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...

Dissociative identity disorder arises as a response to trauma. Understanding its neurobiology offers valuable insights into ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on delivering therapeutics through effective oral delivery, announced today that it has received revised regulatory guidance for LPCN ...